Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer
Ching-Yi Chen,1,2 How-Wen Ko,3 Po-Wei Hu,4 Cheng-Yu Chang,5,6,* Chung-Yu Chen,7,* Shih-Chieh Chang,4,* Yu-Chi Chiu,8,* Yu-Feng Wei9,* 1Division of Chest Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; 2College of...
Saved in:
| Main Authors: | Chen CY, Ko HW, Hu PW, Chang CY, Chang SC, Chiu YC, Wei YF |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Lung Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/impact-of-subsequent-treatment-on-clinical-outcomes-in-patients-with-e-peer-reviewed-fulltext-article-LCTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status and Future Prospects of Treatment for EGFR-Positive Non-Small Cell Lung Cancer After Resistance to EGFR-TKI
by: Yiming ZENG, et al.
Published: (2025-06-01) -
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
by: Azhar Ali, et al.
Published: (2018-02-01) -
Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions
by: Yang Li, et al.
Published: (2025-04-01) -
Diverse perspectives on proteomic posttranslational modifications to address EGFR-TKI resistance in non-small cell lung cancer
by: Yuhong Ma, et al.
Published: (2024-12-01) -
Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register–Based Study
by: Laura S. Puuniemi, et al.
Published: (2025-07-01)